Clinical Trial Update: A Clinical Trial to Evaluate the Food Effect of CKD-378 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of food on the pharmacokinetics of CKD-378 has completed. The trial was conducted by Chong Kun Dang Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-378

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type II Diabetes Mellitus | Phase 1 | Status: COMPLETED